Subscribe to our newsletter to receive the latest product updates and special offers

Egholm Michael - Insider Transactions

Filter
Ticker Owner Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LABEgholm MichaelPresident & CEOApr 04Option Exercise0.00196,5120422,030Apr 05 06:59 PM
LABEgholm MichaelPresident & CEOApr 04Option Exercise0.00196,5120206,512Apr 06 07:02 PM
PLLEgholm MichaelPresident, BioPharmaceuticalsJul 15Option Exercise125.521,595200,2461,596Jul 15 03:35 PM
PLLEgholm MichaelPresident, BioPharmaceuticalsJun 29Option Exercise69.6915,5381,082,77415,539Jun 30 03:29 PM
PLLEgholm MichaelPresident, BioPharmaceuticalsJun 29Sale124.5515,5381,935,2461Jun 30 03:29 PM
PLLEgholm MichaelPresident, BioPharmaceuticalsDec 22Option Exercise58.886,120360,3467,588Dec 23 06:48 PM
PLLEgholm MichaelPresident, BioPharmaceuticalsDec 22Sale100.407,587761,7001Dec 23 06:48 PM
PLLEgholm MichaelChief Technology OfficerJul 14Option Exercise60.794,906298,2772,330Jul 16 05:08 PM
PLLEgholm MichaelChief Technology OfficerJul 14Sale82.032,577211,3920Jul 16 05:08 PM
PLLEgholm MichaelChief Technology OfficerMar 07Sale67.812,942199,5040Mar 08 04:10 PM
PLLEgholm MichaelChief Technology OfficerFeb 04Option Exercise68.514,755325,7884,755Feb 05 06:56 PM
PLLEgholm MichaelChief Technology OfficerJan 10Option Exercise36.641,92570,5321,925Jan 14 07:20 PM
PLLEgholm MichaelChief Technology OfficerJan 10Sale64.211,925123,6010Jan 14 07:20 PM
open in screener